Panoutsopoulou, K., Avgeris, M., Magkou, P., Mavridis, K., Dreyer, T., Dorn, J., . . . Scorilas, A. (2020). miR‐181a overexpression predicts the poor treatment response and early‐progression of serous ovarian cancer patients. International Journal of Cancer, 147(12), 3560-3573. https://doi.org/10.1002/ijc.33182
Citácia podle Chicago (17th ed.)Panoutsopoulou, Konstantina, et al. "MiR‐181a Overexpression Predicts the Poor Treatment Response and Early‐progression of Serous Ovarian Cancer Patients." International Journal of Cancer 147, no. 12 (2020): 3560-3573. https://doi.org/10.1002/ijc.33182.
Citácia podľa MLA (8th ed.)Panoutsopoulou, Konstantina, et al. "MiR‐181a Overexpression Predicts the Poor Treatment Response and Early‐progression of Serous Ovarian Cancer Patients." International Journal of Cancer, vol. 147, no. 12, 2020, pp. 3560-3573, https://doi.org/10.1002/ijc.33182.